Introduction
Quantum physics and phlebology (venous medicine) intersect most visibly through technologies whose operating principles are rooted in quantum-derived optics and electromagnetic theory, notably lasers and light–tissue interaction for venous ablation and imaging[1–4]. A second major bridge is magnetic resonance–based venous imaging and oximetry, where MR phase information is interpreted as magnetic susceptibility and used to quantify venous oxygenation proxies, linking quantum spin physics to venous physiology[5–7]. A third bridge consists of emerging “quantum technologies” in sensing and computation, including SQUID-based biomagnetism and quantum-inspired/quantum machine learning workflows that target biomedical signals relevant to blood flow and vascular states[8, 9].
Across this literature, the “common aspects” are rarely that veins themselves exhibit exotic macroscopic quantum phenomena; rather, phlebology adopts measurement and treatment modalities (lasers, interferometric imaging, magnetometry, MR susceptibility reconstruction) whose physical foundations lie in quantum theory, photonics, and quantum-informed electromagnetic modeling[5, 8, 10].
Therapeutic intersections
Endovenous laser approaches illustrate the most direct translational intersection: coherent laser radiation is delivered inside a vein, and the clinical aim is occlusion of refluxing or incompetent veins through controlled photothermal damage produced by light absorption and heating[1–4]. Mechanistic work emphasizes that absorbed energy is often deposited into intraluminal blood/coagulum around the fiber tip (not only directly in the vein wall), such that coagulation temperatures can be achieved regardless of whether hemoglobin or water is the nominal target chromophore[12]. This frames EVLA/EVLT/EVLP not merely as a “wavelength label,” but as a coupled photon-absorption, heat-generation, and heat-transfer process dependent on scattering and absorption properties at the wavelength used[13].
In vitro work using a solid-state laser at 1.885 μm and ~3 W examined how the presence of intraluminal red blood cell suspension versus saline, and the formation of a heated carbonized layer on the fiber end face, affects ablation efficiency[1]. In that study, the presence of the heated carbonized layer increased EVLA efficiency, highlighting a thermochemical pathway that can amplify energy deposition at the tip beyond simple optical absorption in blood alone[1]. Related mechanistic arguments explain why wavelength selectivity can diminish during the procedure: coagulum can form around the tip and be partly transformed into carbon at temperatures exceeding 1,000 °C, and because carbon absorbs all EVLA laser wavelengths equally well, carbonization can reduce wavelength dependence once tip heating is dominated by carbon absorption[13].
Clinical comparisons further reinforce the translational physics-to-phlebology pipeline. In one patient series, total great saphenous vein obliteration persisted across follow-up, and EVLA at 1560 nm and 1940 nm was described as highly effective and safe for correcting venous reflux in lower-extremity varicose veins[11]. Optical-parameter studies support why wavelength choice remains important even if carbonization can blunt selectivity: penetration depths in the vein wall were reported as ~1.3 mm at 980 nm versus ~0.22 mm at 1470 nm, implying very different spatial energy deposition profiles and potential collateral injury patterns[14].
Wavelength selection is also explicitly treated within EVLP system evolution, where multiple wavelengths are positioned as having different absorption characteristics; for example, 810 nm is described as specific for hemoglobin absorption, and a large clinical study set out to compare efficacy and safety of EVLP at 1064 nm versus 810 nm for chronic venous insufficiency (varicose veins)[2]. Separate optical analyses argue for potentially favorable mid-infrared choices, noting that “the best results so far” were obtained with 1.56-mm radiation, and that at wavelengths of 1.68 and 1.7 mm absorption in nonaqueous blood components is much weaker than absorption in water, motivating water-dominant targeting hypotheses at these longer wavelengths[15].
A distinct non-thermal therapeutic intersection is photochemical venous therapy via photo-collagen cross-linking, where riboflavin is used as a cross-linking agent and blue light acts as the activator[16]. In venous specimens, this approach produced fast and significant shrinkage without histologic evidence of endothelial damage and with evident changes in mechanical properties of varicose veins, suggesting a controllable light-activated remodeling mechanism rather than purely thermal ablation[16].
Diagnostic intersections optical and photonic
Optical diagnosis in phlebology frequently exploits the fact that hemoglobin has wavelength-dependent absorption properties, enabling noninvasive interrogation of venous oxygenation, thrombus composition, or vascular structure using photons as probes[3, 4, 17]. Across methods, the common physics is that measured signals (attenuation, interference fringes, photoacoustic pressure transients, fluorescence emission) are ultimately driven by photon absorption and scattering in blood and vessel wall constituents[3, 10, 18].
Near-infrared spectroscopy
Near-infrared (NIR) spectroscopy is described as a noninvasive technique that uses the differential absorption properties of hemoglobin to evaluate skeletal muscle oxygenation, and monitoring selected wavelengths can provide an index of deoxygenation[3]. One study explicitly measured venous oxygen saturation and 760–800 nm absorption during forearm exercise to test whether the optical absorption band correlates with venous oxygenation[3]. A separate method used NIRS with venous occlusion to measure peripheral venous oxyhemoglobin saturation (SvO2) noninvasively in the adult forearm[19], and reported a significant correlation between forearm SvO2 measured by NIRS and superficial venous blood SvO2 measured by co-oximetry (n=19, r=0.7, p<0.0001)[19].
Other validation work examined relationships between NIRS signals and venous hemoglobin oxygen saturation (O2Hb%) and venous oxygen concentration (CvO2)[20]. After normalization to physiological range, high linear correlations were reported between deoxygenated and oxygenated heme signals and venous O2Hb% (R≈0.92) and between heme signals and CvO2 (R≈0.89–0.90), indicating that photon-absorption-based NIRS measurements can track venous oxygenation metrics in controlled settings[20]. In central venous contexts, NIRAS was reported to provide an accurate noninvasive measurement of cerebral venous saturation, with CSvO2 calculated by NIRAS and compared to direct co-oximetry of blood from the internal jugular vein[21].
Photoplethysmography
Photoplethysmography (PPG) relies on an infrared light source and receptor to approximate fluctuations in blood volume, and it estimates volume changes by measuring the amount of light absorbed and reflected back to the receptor[22]. In a chronic venous insufficiency evaluation setting, venous hemodynamic values provided by digital PPG were used alongside standard evaluation to investigate whether intervention (EVLA) was required, and correlations between Doppler ultrasound and D-PPG were examined to assess whether D-PPG could help in understanding venous pathology and evaluating treatment options[22]. The method is also contextualized historically as originally introduced in the 1930s as a means of evaluating the vascular system, emphasizing its role as an established optical proxy for hemodynamics[22].
Optical coherence tomography
Optical coherence tomography (OCT) is described as a powerful imaging modality based on low-coherence interferometry, enabling high-resolution imaging with tissue penetration depths of a few millimeters and near-histological visualization of vessel walls[10, 23, 24]. Endovascular OCT has been presented as providing “histology-like information” of the venous wall[4], and one application frames endovascular OCT as the highest-resolution intravascular imaging technique available using near-infrared light at approximately 1300 nm[25]. In venous-therapy assessment, OCT was evaluated for qualitative assessment of venous wall anatomy and tissue alterations after radiofrequency ablation and endovenous laser therapy in bovine venous specimens, including reporting ELT parameters of a diode laser at 980 nm with energy densities of 15, 25, and 35 J/cm[4].
OCT is also positioned for intracranial venous applications: adoption in the human cerebral venous sinus “could aid” diagnosis, treatment, and understanding of dural arteriovenous fistulas, cerebral venous sinus thrombosis, and idiopathic intracranial hypertension[25]. This exemplifies how interferometric photon-based imaging can extend phlebology beyond superficial leg veins into venous sinus pathology, contingent on catheter-based access and optical signal constraints[25].
Polarization-sensitive OCT
Polarization-sensitive OCT (PS-OCT) extends OCT by measuring tissue birefringence, providing contrast for collagen and smooth muscle cells that are present in older, chronic clots[26]. In a rat DVT model, intravascular PS-OCT was investigated to assess thrombus morphology and composition in vivo across thrombus aging[26]. Automated analysis of OCT cross-sectional images differentiated acute and chronic thrombi with 97.6% sensitivity and 98.6% specificity using a linear discriminant model combining polarization and conventional OCT metrics, supporting PS-OCT as a sensitive approach for DVT composition assessment and thrombus-age differentiation[26].
Photoacoustic imaging and elastography
Photoacoustic imaging (PAI) is described as enabling remote measurements of tissue optical absorption, and its contrast is generated via the photo/opto/thermoacoustic effect in which absorption of a short electromagnetic pulse produces a thermoelastic acoustic wave[17, 27]. In practice, biological tissues are irradiated with non-ionizing laser pulses; absorption increases local temperature (on the order of a few millikelvin), leading to thermoelastic expansion and acoustic emission[18]. Red blood cells, which contain hemoglobin and absorb visible light significantly, rapidly increase in temperature and pressure upon absorbing light energy, providing a physiologically meaningful endogenous absorber for clot and blood-vessel imaging[28].
In DVT staging concepts, clot reorganization can decrease hemoglobin concentration and thereby reduce optical absorption, motivating the use of photoacoustic signal changes to stage thrombi noninvasively[27]. One study further specifies that pulsed laser radiation with wavelength tuned to RBC absorption can be used, and proposes that acute blood clots should emit stronger photoacoustic signals than chronic DVT because of stronger optical absorption[27]. Empirically, combined ultrasound and photoacoustic imaging was reported to provide information about the structure and age of DVT thrombi, while broader reviews note PAI’s promise due to its spatial resolution and high optical contrast[17, 29].
Beyond absorption-based staging, vascular elastic photoacoustic tomography (VE-PAT) connects optical absorption detection to mechanical property inference. PAT achieves high spatial resolution beyond the optical diffusion limit by ultrasonically detecting optical absorption, and it is highlighted as having strong hemoglobin-based absorption contrast in RBCs and as being capable of providing structural, functional, and mechanical properties of blood vessels in animals and humans[30]. VE-PAT was reported as capable of measuring vascular elastic properties in humans[30], detecting decreased vascular compliance due to simulated thrombosis in large-vessel phantoms (validated by standard compression testing)[30], and detecting a decrease in vascular compliance in a human subject when downstream occlusion occurred, demonstrating potential for deep venous thrombosis detection[30].
Near-infrared fluorescence and hyperspectral imaging
Near-infrared fluorescence (NIRF) thrombus imaging uses targeted fluorophores to convert molecular binding events into detectable NIR photon emission; for example, a fibrin-targeted peptide was conjugated to the near-infrared fluorophore Cy7 (FTP11-Cy7) to develop and validate an imaging agent enabling high-resolution NIRF imaging of deep vein thrombosis[31]. In preclinical workflows, noninvasive integrated fluorescence molecular tomography with CT (FMT-CT) was performed in mice with sub-acute jugular vein DVT, illustrating a combined optical–radiologic approach to thrombus localization and quantification[31]. Related work emphasizes that fluorescence imaging in the second near-infrared window (NIR-II, 1,000–1,700 nm) is favorable due to reduced equipment complexity and easier operation, and that a theranostic drug carrier was developed to enable real-time monitoring of the targeted thrombolytic process of DVT[32].
At the surface-imaging end of the spectrum, hyperspectral visible–NIR imaging delineates varicose veins by exploiting wavelength-dependent diffuse reflection signatures. In one system study, volunteers were illuminated with polychromatic light spanning 400–950 nm[33], and diffuse reflection spectra peaked at 530 nm for varicose veins versus 780 nm for leg veins[33]. Hyperspectral images at selected wavelengths were normalized and filtered prior to delineation using quantitative phase analysis and k-means clustering, linking optical spectra to computational segmentation for noncontact vein mapping[33].
Diagnostic intersections magnetic resonance
Quantitative susceptibility mapping (QSM) provides a magnetic resonance bridge between quantum spin physics and venous physiology by using MR phase evolution to infer local magnetic susceptibility. QSM “examines gradient-echo phase data” to determine local tissue magnetic susceptibility[5], and measuring susceptibility differences from QSM is reported to make it possible to quantify SvO2 values based on the relationship between susceptibility difference and SvO2[6]. Oxygenation sensitivity is supported by reports that QSM can quantify changes in deoxyhemoglobin saturation induced by hyperoxic gas challenge in both animal models and humans[7], and by reported excellent agreement between ShvO2 measured on a blood gas analyzer and ShvO2 calculated from QSM measurements[7].
The venous specificity of susceptibility-based metrics is grounded in the magnetic property contrast between oxygenation states: oxyhemoglobin is described as diamagnetic (negative susceptibility) whereas deoxyhemoglobin is paramagnetic (positive susceptibility)[28]. Within the provided QSM literature excerpts, QSM is also framed as a noninvasive method that may provide an indirect measure of cerebral venous oxygen saturation (CSvO2), reinforcing its potential for venous oximetry applications where direct sampling is impractical[5].
Quantum biophysical mechanisms
At the molecular level, hemoglobin’s oxygenation state is linked to magnetic properties that are directly relevant to both magnetic-field interactions and MR susceptibility imaging. Oxyhemoglobin is described as diamagnetic while deoxyhemoglobin is paramagnetic, implying oxygenation-dependent susceptibility and magnetic-force interactions at the molecular/electronic level[28]. Hemoglobin is also described as an allosteric protein that undergoes conformational change during tense (deoxygenated) to relaxed (oxygenated) transitions and vice versa, emphasizing that oxygen binding is coupled to protein structural state[28].
A proposed mechanistic bridge between electromagnetic fields and blood physiology is that magnetic fields affect moving charges and thus the allosteric transformation of hemoglobin, which is described as involving shifts of populations rather than a unidirectional conversion of one quaternary structure to another[28]. In the context of venous medicine, this body of claims connects quantum-informed magnetism concepts (susceptibility, field–charge interactions) to hemoglobin function, which underlies venous oxygen content and oxygen unloading dynamics that optical (NIRS, PAI) and MR (QSM) methods attempt to measure[3, 6, 28].
Emerging and conceptual intersections
Several lines of work extend beyond established clinical phlebology devices, but still articulate quantum-physics-derived principles applied to vascular or venous signals. In EVLA, computational modeling is explicitly motivated by representing the laser fiber as a point source in a cylindrical venous tube and modeling radial redistribution of light via a diffusion process governed by blood scattering and absorption at the wavelength considered, illustrating a physics-forward approach to parameter optimization in venous ablation[13].
Bioelectronic devices branded as “Quantum Molecular Resonance” (QMR) are also discussed as potential tools in phlebology: a “new type of electric scalpel” is described as usable to treat dermal capillaries and varicosities, with adjustable power and precise timing intended to reduce thermal damage[34]. In the same framing, sclerotherapy is described as the primary treatment for varicose veins, spider veins, and telangiectasias, positioning QMR as an adjunct in the broader therapeutic ecosystem of superficial venous disease management[34].
On the computational side, a hybrid quantum–classical machine-learning approach has been reported for laser speckle contrast imaging (LSCI) of blood flow: instead of using a standard 3D global pooling layer to compress feature maps, the model replaces it with a variational quantum circuit, and the circuit is claimed to preserve spatial and temporal relationships in the data to maintain predictive accuracy[9]. Although not venous-disease-specific in the excerpt, the intersection is that blood-flow imaging pipelines relevant to vascular assessment can be modified by explicitly quantum circuit components, linking quantum information processing to hemodynamic signal analysis[9].
A separate modeling concept proposes a technique “entirely based on Quantum Mechanics and Classical Electrodynamics” to address anomalous vessel growth during angiogenesis, and claims to use quantum mechanics calculations to more accurately predict the location and detain anomalous growth of vessels[35]. While this sits closer to vascular biology and angiogenesis than to classical varicose vein management, it still represents a direct attempt to use quantum/electrodynamics modeling as a guide for interventions in pathological vessel formation[35].
Finally, quantum sensing connects to venous states via biomagnetism. SQUIDs are described as being based on magnetic flux quantization and the Josephson effect[8], and related quantum sensors detect precession of atomic spins in a magnetic field with sensitivities near femtoteslas per [8]. In an application explicitly involving venous ischemia, studies reported that changes occur prior to pathologic changes and can be recorded noninvasively using a SQUID[36], and SQUIDs are described as measuring magnetic fields created by the electrical activity of gastrointestinal smooth muscle, demonstrating feasibility of capturing weak bioelectromagnetic signatures relevant to vascular compromise states[36].
Synthesis
Across the sampled literature, several cross-cutting “common aspects” consistently link quantum physics to phlebology through shared measurable quantities, controllable parameters, and instrument physics.
The table below summarizes recurring bridges from quantum-derived physical principles to concrete venous applications.
Taken together, these themes show that the shared “language” between quantum physics and phlebology is largely a language of measurable contrasts and controllable parameters: absorption spectra and wavelength, coherence and interference, polarization state, susceptibility, and sensor sensitivity limits[3, 5, 8, 10].
Limitations and conclusion
Within the literature sampled here, the dominant intersections are applied and translational: lasers are deployed for endovenous ablation and compared across wavelengths for efficacy and safety, optical spectroscopy and imaging are used to infer venous oxygenation or characterize thrombi, and MR susceptibility reconstruction is used to quantify venous oxygenation proxies[3, 6, 11, 17]. The closest links to more “fundamental” molecular physics are (i) hemoglobin’s oxygenation-dependent magnetic susceptibility (diamagnetic oxyhemoglobin vs paramagnetic deoxyhemoglobin) and (ii) susceptibility-based QSM methods that exploit these differences to quantify oxygenation changes, along with claims that magnetic fields can affect hemoglobin allosteric transformations through moving-charge interactions[7, 28].
Overall, the common aspects of quantum physics and phlebology documented in this corpus are best understood as the clinical deployment of quantum-founded photonics and electromagnetic measurement science to diagnose, image, and treat venous disease, with hemoglobin serving as a central “bridge molecule” that is simultaneously a therapeutic absorber, an optical reporter, and a magnetic susceptibility source[3, 12, 28].
